PRDM1 anticorps (Middle Region)
Aperçu rapide pour PRDM1 anticorps (Middle Region) (ABIN2792524)
Antigène
Voir toutes PRDM1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Séquence
- VEDDISVISV VEKEILAVVR KEKEETGLKV SLQRNMGNGL LSSGCSLYES
-
Réactivité croisée
- Boeuf (Vache), Humain, Souris, Rat (Rattus)
-
Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 84%, Horse: 100%, Human: 100%, Mouse: 92%, Pig: 100%, Rabbit: 92%, Rat: 92%
-
Attributs du produit
- This is a rabbit polyclonal antibody against PRDM1. It was validated on Western Blot using a cell lysate as a positive control.
-
Purification
- Affinity Purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of human PRDM1
-
-
-
-
Indications d'application
-
WB Suggested Anti-PRDM1 Antibody Titration: 0.2-1 µg/mL
ELISA Titer: 1:62500
Positive Control: SH-SYSY cell lysate.
Optimal working dilutions should be determined experimentally by the investigator. -
Commentaires
-
Antigen size: 691 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
: "VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection. ..." dans: Cancer cell, Vol. 28, Issue 2, pp. 210-24, (2015) (PubMed).
-
: "VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection. ..." dans: Cancer cell, Vol. 28, Issue 2, pp. 210-24, (2015) (PubMed).
-
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
-
Autre désignation
- PRDM1 / BLIMP1
-
Sujet
-
PRDM1 is a protein that acts as a repressor of beta-interferon gene expression. The protein binds specifically to the PRDI (positive regulatory domain I element) of the beta-IFN gene promoter. Transcription of this gene increases upon virus induction. Two alternatively spliced transcript variants that encode different isoforms have been reported. This gene encodes a protein that acts as a repressor of beta-interferon gene expression. The protein binds specifically to the PRDI (positive regulatory domain I element) of the beta-IFN gene promoter. Transcription of this gene increases upon virus induction. Two alternatively spliced transcript variants that encode different isoforms have been reported.
Alias Symbols: BLIMP1, MGC118922, MGC118923, MGC118924, MGC118925, PRDI-BF1
Protein Interaction Partner: PRMT5, SENP1, EHMT2, PIAS1, SUMO1, IRF2, IRF1, HDAC2, HDAC1, HIST1H1A, MS4A1, HSP90AA1, ATXN1, ELAVL1, KDM1A, IRF4, TLE2, TLE1, AES, PRMT7, HIST2H3A,
Protein Size: 691 -
Poids moléculaire
- 77 kDa
-
ID gène
- 639
-
NCBI Accession
- NM_182907, NP_878911
-
UniProt
- Q86WM7
-
Pathways
- Regulation of Muscle Cell Differentiation
Antigène
-